Alaunos Therapeutics Inc (TCRT)
2.39
+0.07
(+3.02%)
USD |
NASDAQ |
Nov 22, 16:00
2.355
-0.04
(-1.46%)
After-Hours: 20:00
Alaunos Therapeutics Enterprise Value: 2.144M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 2.144M |
| November 21, 2024 | 2.032M |
| November 20, 2024 | 1.728M |
| November 19, 2024 | 1.696M |
| November 18, 2024 | 1.744M |
| November 15, 2024 | 1.664M |
| November 14, 2024 | 2.060M |
| November 13, 2024 | 2.160M |
| November 12, 2024 | 2.224M |
| November 11, 2024 | 1.680M |
| November 08, 2024 | 1.495M |
| November 07, 2024 | 1.552M |
| November 06, 2024 | 1.776M |
| November 05, 2024 | 1.584M |
| November 04, 2024 | 1.534M |
| November 01, 2024 | 1.584M |
| October 31, 2024 | 1.600M |
| October 30, 2024 | 1.551M |
| October 29, 2024 | 1.632M |
| October 28, 2024 | 1.614M |
| October 25, 2024 | 1.792M |
| October 24, 2024 | 1.840M |
| October 23, 2024 | 2.144M |
| October 22, 2024 | 1.952M |
| October 21, 2024 | 1.776M |
| Date | Value |
|---|---|
| October 18, 2024 | 1.936M |
| October 17, 2024 | 1.856M |
| October 16, 2024 | 2.181M |
| October 15, 2024 | 1.856M |
| October 14, 2024 | 1.648M |
| October 11, 2024 | 1.696M |
| October 10, 2024 | 1.856M |
| October 09, 2024 | 1.840M |
| October 08, 2024 | 2.368M |
| October 07, 2024 | 2.624M |
| October 04, 2024 | 2.528M |
| October 03, 2024 | 2.705M |
| October 02, 2024 | 3.377M |
| October 01, 2024 | 3.449M |
| September 30, 2024 | 3.473M |
| September 27, 2024 | 2.517M |
| September 26, 2024 | 3.206M |
| September 25, 2024 | 3.846M |
| September 24, 2024 | 2.901M |
| September 23, 2024 | 2.533M |
| September 20, 2024 | 1.957M |
| September 19, 2024 | 2.053M |
| September 18, 2024 | 2.533M |
| September 17, 2024 | 1.444M |
| September 16, 2024 | 0.9798M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-1.188M
Minimum
Dec 12 2023
1.087B
Maximum
Feb 08 2021
270.21M
Average
185.07M
Median
Nov 25 2022
Enterprise Value Benchmarks
| Microbot Medical Inc | 12.26M |
| SELLAS Life Sciences Group Inc | 61.32M |
| Galectin Therapeutics Inc | 254.19M |
| Oragenics Inc | 2.314M |
| Anavex Life Sciences Corp | 633.73M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.127M |
| Total Expenses (Quarterly) | 1.15M |
| EPS Diluted (Quarterly) | -0.70 |
| Earnings Yield | -310.0% |
| Normalized Earnings Yield | -345.13 |